Fritsch-Buttenberg-Wiechell rearrangement of magnesium alkylidene carbenoids leading to the formation of alkynes.

A series of 1-heteroatom-substituted vinyl p-tolyl sulfoxides were prepared and treated with organometallic reagents to evaluate which combination of sulfoxides and organometallic reagents yielded alkynes the most efficiently. The use of 1-chlorovinyl p-tolyl sulfoxide and isopropylmagnesium chloride was optimal for this purpose. A variety of 1-chlorovinyl p-tolyl sulfoxides were prepared from carbonyl compounds and chloromethyl p-tolyl sulfoxide and were converted into alkynes via the sulfoxide/magnesium exchange reaction and subsequent Fritsch-Buttenberg-Wiechell (FBW) rearrangement of the resulting magnesium alkylidene carbenoids. The mechanism of the FBW rearrangement of magnesium alkylidene carbenoids was studied by using 13C-labeled sulfoxides and by using DFT calculations.

Studies on stress distribution in pavements subjected to surface shear forces.

It has been pointed out by some researchers that road pavements are subjected to vertical stress due to vehicles on them as well as shear stress at the time of braking or acceleration of vehicles. In this paper, the results of elastic analysis to obtain the rigorous solution for an elastic two-layer system subjected to surface shear stress are described and it is shown that the effect of shear stresses applied at the surface gives rise to fairly large stresses in the system. On the basis of these findings, the author attempts to explain why pavement failure takes place frequently at places such as crossings and curved parts where pavements are subjected to high magnitude of surface shear stresses.

Respiratory and cardiovascular toxicity studies of a novel antiprion compound, GN8, in rats and dogs.

Prion diseases, also known as transmissible spongiform encephalopathies, are fatal neurodegenerative disorders for which no effective curative or prophylactic method has been established. Recently, we discovered a novel antiprion compound, GN8. Administration of GN8 was found to prolong the survival of prion-infected mice. The aim of this study was to characterize the toxicological and pharmacological features of GN8 in rats and dogs treated via a single intravenous injection. Minimum lethal doses of GN8 were estimated to be approximately 60 and 40 mg/kg in rats and dogs, respectively. In the respiratory toxicity experiments, GN8 was administered to rats at doses of 0, 15.6, and 46.9 mg/kg, and rats were observed for consciousness, behavior, autonomic nervous symptoms, and body weights. GN8 was found to have little adverse effect on the rat respiratory system at a dose of 46.9 mg/kg. In the cardiovascular toxicity experiments, GN8 was administered to dogs at doses of 0, 7.8, and 31.3 mg/kg, and dogs were observed similarly. Although GN8 was found to have a slight effect on the cardiovascular system at a dose of 31.3 mg/kg, we did not find severe adverse effects of GN8 at doses sufficient for antiprion activity. This study would serve as a stepping stone to a clinical application of GN8 as an antiprion agent.

Synthesis of GN8 derivatives and evaluation of their antiprion activity in TSE-infected cells.

A series of GN8 derivatives were synthesized from various diamines, carboxylic acid derivatives, and nitrogen nucleophiles, and their antiprion activity was tested in TSE-infected mouse neuronal cells. We found that two ethylenediamine units, hydrophobic substituents on the nitrogen atoms, and the diphenylmethane scaffold were essential structural features responsible for the activity. Seven derivatives bearing substituents at the benzylic position exhibited an improved antiprion activity with the IC(50) values of 0.51-0.83 µM. Conformational analysis of model compounds suggested that the introduction of the substituent at the benzylic position restricted the conformational variability of the diphenylmethane unit.

Discovery of a multipotent chaperone, 1-(2,6-Difluorobenzylamino)-3-(1,2,3,4-tetrahydrocarbazol-9-yl)-propan-2-ol with the inhibitory effects on the proliferation of prion, cancer as well as influenza virus.

We previously discovered three carbazole derivatives, GJP14 (1-piperidinylmethyl-2-(1-oxo-6-methyl-1,2,3,4-tetrahydrocarbazol-9-yl)-ethan-1-ol) with anti-prion activity, GJC29 (benzylamino-3-(1,2,3,4-tetrahydrocarbazol-9-yl)-propan-2-ol) with anti-cancer activity, and THC19 (1-piperidinylmethyl-2-(1,2,3,4-tetrahydrocarnazol-9-yl)-ethan-1-ol) with anti-influenza virus activity. During optimization of GJP14 for the anti-prion activity, we discovered a compound, 1-(2,6-difluorobenzylamino)-3-(1,2,3,4-tetrahydrocarbazol-9-yl)-propan-2-ol, termed 5Y, had the most strong anti-prion activity among a series of newly synthesized derivatives. Intriguingly, we noticed that 5Y had also the most strong anti-colon cancer as well as the anti-influenza virus activities among derivatives. No significant toxicity of 5Y was observed. These results demonstrate that 5Y is a multipotent lead compound with unusually wide spectrum, and may be applicable to therapeutics targeting multiple diseases.Abbreviations: MoPrP: mouse prion protein of amino acid residues of 23-231; PrPC: cellular form of prion protein; PrPSc: scrapie form of prion protein.

A designer molecular chaperone against transmissible spongiform encephalopathy slows disease progression in mice and macaques.

Transmissible spongiform encephalopathies (TSEs) are fatal neurodegenerative diseases that lack therapeutic solutions. Here, we show that the molecular chaperone (N,N'-([cyclohexylmethylene]di-4,1-phenylene)bis(2-[1-pyrrolidinyl]acetamide)), designed via docking simulations, molecular dynamics simulations and quantum chemical calculations, slows down the progress of TSEs. In vitro, the designer molecular chaperone stabilizes the normal cellular prion protein, eradicates prions in infected cells, prevents the formation of drug-resistant strains and directly inhibits the interaction between prions and abnormal aggregates, as shown via real-time quaking-induced conversion and in vitro conversion NMR. Weekly intraperitoneal injection of the chaperone in prion-infected mice prolonged their survival, and weekly intravenous administration of the compound in macaques infected with bovine TSE slowed down the development of neurological and psychological symptoms and reduced the concentration of disease-associated biomarkers in the animals' cerebrospinal fluid. The de novo rational design of chaperone compounds could lead to therapeutics that can bind to different prion protein strains to ameliorate the pathology of TSEs.

Enantiomerically pure P-chiral phosphinoselenoic chlorides: inversion of configuration at the P-chirogenic center in the synthesis and reaction of these substances.

Reaction of diastereomerically pure phosphinoselenoic acid salts with oxalyl chloride leads to enantiomerically pure P-chiral phosphinoselenoic chlorides with inversion of configuration at phosphorus; one of these chlorides is converted to a phosphinoselenothioic acid salt with a high degree of enantioselectivity.

Evaluation of primary and secondary responses to a T-cell-dependent antigen, keyhole limpet hemocyanin, in rats.

To develop a rat T-cell-dependent antibody response (TDAR) model evaluating both primary and secondary antibody responses, keyhole limpet hemocyanin (KLH) was used to immunize rats twice during a 14-day course of study, a pattern closely linked to that of a short-term general toxicity study. Female rats of four representative strains (e.g., Sprague-Dawley, Wistar, Fischer, and Lewis) were immunized twice with intravenous administrations of KLH (300 µg/rat) on Days 5 and 9 during a 14-day treatment regimen with cyclophosphamide (CPA) at 1, 3, or 6 mg/kg/day. The primary and secondary immunizations of KLH markedly elevated serum anti-KLH IgM and IgG levels in all strains on Days 9 and 15. Remarkable higher levels of anti-KLH IgG (≈ 1000 µg/ml) were noted in all strains, which were more than 4-times compared with those of anti-KLH IgM levels at Day 9, indicating that predominant IgG reactions were induced by the dual immunizations. A large inter-individual variability in KLH-specific IgM and IgG production was observed in all strains. However, levels of the KLH-specific antibodies were considered sufficient for the evaluation, even in Sprague-Dawley and Wistar rats reported as strains with a wide range of variability since immunosuppression of CPA on responses in both anti-KLH IgM and IgG were observed in all strains to the same extent. In addition, the sensitivity of the KLH-ELISA assay system detecting the immunosuppressive effects of CPA was comparable to other assay systems with PFC assay or ELISA using SRBC. The results here demonstrated that these experimental designs could provide valuable information about the influence on both the primary and secondary humoral immune responses in rats when exposed to potential immunomodulatory drugs. Furthermore, the design of the presented TDAR study would support comprehensive evaluation together with the outcome of the conventional general toxicity study.

Synthesis of an (11) C-labeled antiprion GN8 derivative and evaluation of its brain uptake by positron emission tomography.

A radiolabeled PET! A (11) C-labeled derivative of N,N'-(methylenedi-4,1-phenylene)bis[2-(1-pyrrolidinyl) acetamide] (GN8), an antiprion agent currently under development, was synthesized by palladium-catalyzed rapid methylation of aryltributylstannane and assessed for brain penetration and organ distribution in rats by positron emission tomography (PET).

Synthesis of 9-substituted 2,3,4,9-tetrahydro-1H-carbazole derivatives and evaluation of their anti-prion activity in TSE-infected cells.

2,3,4,9-Tetrahydro-9-[2-hydroxy-3-(1-piperidinyl)propyl]-6-methyl-1H-carbazol-1-one (GJP14) is a novel anti-prion compound that we previously discovered by in silico screening and cellular assay. In this study, a variety of GJP14 derivatives were prepared using pyrrole derivatives, (haloalkyl)oxiranes, and amines, and their anti-prion activity was evaluated in TSE-infected cells. It was found that the tricyclic aromatic ring, a hydroxy group at the 2-position and an amino group at the 3-position of the N-propyl group were the basic requirements for anti-prion activity. The derivatives bearing an N-ortho-halobenzyl group exhibited an improved activity, and the most potent derivative was 8 times as effective as the original lead compound, GJP14.

P-chiral phosphinoselenoic chlorides and phosphinochalcogenoselenoic acid esters: synthesis, characterization, and conformational studies.

P-Chiral alkyl or aryl phenylphosphinoselenoic chlorides were obtained by reacting PhPCl(2) with Grignard reagents and elemental selenium. P-Chiral dialkyl chlorides were also obtained by treating PCl(3) with two different Grignard reagents and elemental selenium. The structure of the chloride was determined by X-ray molecular structure analysis. P-Chiral phosphinochalcogenoselenoic acid esters bearing a P=Se double bond were synthesized by treating the chlorides with alkali metal alkoxide and chalcogenolates, whereas those bearing a P-Se single bond were obtained by sequential treatment of the chlorides with sodium hydroxide, sulfide or selenide, and alkyl iodides. X-ray molecular structure analyses of esters showed that they adopted gauche conformations. The computational results supported the observed conformational preference. Natural bond orbital analyses of the model compounds showed that two types of nonbonding orbital interactions, n(E') -->sigma*(P=E') and n(E) --> sigma*(P-E'), are important in these compounds. Linear correlations were observed between the experimental (77)Se NMR chemical shifts or the coupling constants of P-Se bonds in the esters and the calculated P-Se bond lengths of the model compounds.

Phosphinoselenothioic acids and their salts: synthesis, characterization, and reaction with electrophiles.

[reaction: see text] Phosphinoselenothioic acid ammonium salts were synthesized in good yields by reacting phosphinoselenothioic acid S-[2-(trimethylsilyl)ethyl] esters with ammonium fluorides. Phosphinoselenothioic acid alkali metal salts were obtained as 18-crown-6 ether complexes with high efficiency by treating the esters with alkali metal fluorides and 18-crown-6 ether. The salts were stable under air and soluble in water. The structures of the phosphinoselenothioic acid tetramethylammonium salt and P-methylseleno-P-methylthiophosphonium triflate were determined by X-ray molecular structure analyses. These salts exhibited monomeric structures, and the central phosphorus atoms adopted tetrahedral structures. Alkylation of the ammonium salts selectively gave phosphinoselenothioic acid Se-alkyl esters, whereas acylation of the salts preferentially gave S-acyl products. Protonation of the salts selectively gave the phosphinoselenothioic S-acid. The S-acid generated in situ was reacted with alpha,beta-unsaturated carbonyl compounds and cyclohexene oxide to give the adducts. Molecular orbital calculations were carried out for the model compound H2P(Se)S- to elucidate the electronic structure.